Evidence map›Paper›PMID 34884170›Full record

ReviewJournal of clinical medicine2021

Marek Szaliński, Aleksandra Zgryźniak, Izabela Rubisz, Małgorzata Gajdzis, Radosław Kaczmarek, Joanna Przeździecka-Dołyk

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. FromJournal of fungi (Basel, Switzerland) · 2026
    Article
  4. Review
  5. A 3DmSphere · 2025
    Article
  6. Antifungal Mechanism Effect of Artemisinin onPharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Article
  8. The Dual PathogenJournal of fungi (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Article
  11. Antifungal susceptibility, clinical findings, and biofilm resistance of Fusarium species causing keratitis: a challenge for disease control.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  12. Article
  13. Review
  14. Biofilm Formation in Clinical Isolates ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marek SzalińskiDepartment of Ophthalmology, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland.
Aleksandra ZgryźniakClinic of Ophthalmology, University Teaching Hospital, ul. Borowska 213, 50-556 Wrocław, Poland.
Izabela RubiszOkulus Ophthalmology Clinic, ul. Śródmiejska 34, 62-800 Kalisz, Poland.
Małgorzata GajdzisDepartment of Ophthalmology, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland.
Radosław KaczmarekDepartment of Ophthalmology, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland.ORCID 0000-0001-9920-4406
Joanna Przeździecka-DołykDepartment of Ophthalmology, Wroclaw Medical University, ul. Borowska 213, 50-556 Wrocław, Poland.ORCID 0000-0002-1099-4876
Wroclaw Medical University · PLWroclaw University of Health and Sport Sciences · PLWrocław University of Science and Technology · PL

Funding

Wrocław Medical University SUB.C240.21.036
6 · The paper itself

Abstract

In many parts of the world, fungi are the predominant cause of infectious keratitis; among which,

Indexed as

amphotericin BFusarium keratitisFusarium keratitis treatmentnatamycinvoriconazole

Identifiers

PMID34884170
PMCPMC8658515
OpenAlexW3215499286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.